Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.170
0.00 (0.00%)
Nov 19, 2025, 4:00 PM EST - Market closed
Evogene Market Cap
Evogene has a market cap or net worth of $10.31 million as of November 20, 2025. Its market cap has decreased by -20.19% in one year.
Market Cap
10.31M
Enterprise Value
17.39M
1-Year Change
-20.19%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $10.31M, a decrease of -63.21%. That is a compound annual growth rate of -5.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 10.31M | -20.73% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | 170.86M | 335.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.29B |
| Johnson & Johnson | 481.86B |
| AbbVie | 413.34B |
| UnitedHealth Group | 284.05B |
| AstraZeneca | 276.37B |
| Novartis AG | 244.75B |
| Merck & Co. | 239.34B |
| Abbott Laboratories | 226.05B |